FCAD Added Prostaglandin Analogues to Product Line

Glaucoma is a leading cause of irreversible blindness in the United States and the rest of the world. More than three million Americans suffer from glaucoma. Furthermore, it is estimated that about 80 million people globally will be affected by 2020.

Prostaglandin analog eye drops are considered first line treatment for glaucoma. These eye drops reduce the intraocular pressure by 20 to 30 percent. Currently there are four different types of analogs available for treating this disease; bimatoprost, travoprost, tafluprost and latanoprost. Out of these four, bimatoprost and travoprost are the most effective in treating this condition. In addition to curing glaucoma, these medications are also used for cosmetic purposes. They can promote eyelash growth and thicken them.

The recommended dose for all 4 medications is 1 drop administered once a day in each eye. Frequent use of these eye drops has shown effective results on lowering the intraocular pressure, thus helps people to get rid of glaucoma.

Here’s a review of the two most important prostaglandin analogs used for treating glaucoma:


This eye drop is available as a concentrated 0.03% solution. It possesses the tendency of causing conjunctival hyperemia; however, chances are rare.

The bimatoprost solution is manufactured and sold under the name, Lumigan eye drops. This solution is available in 2.5 ml, 5 ml and 7.5 ml quantities. Being a new type of analog, it does not degenerate, thus can easily be sold in large quantities.

This medication should not be used without prescription. Bimatoprost has certain side effects, especially if you are suffering from an allergy. Speak to your doctor to see if this is the right medication for you.


Travoprost is sold under the name, Travatan and Travatan Z. It is available in 2.5 ml solution, 4 ml bottle, 5 ml solution and in a 7.5 ml bottle.

Prior to Travatan Z, benzalkonium chloride was used as an effective treatment for glaucoma. It is a known ocular irritant preservative with Sofzia, an ionic buffered preservative that is gentler on the ocular surface.

Both these analogs are an effective group of eye drops for treating glaucoma. Dosing and side effect profile of both the analogs are similar, thus the choice of prostaglandin analog is most dependent on cost, preservation and tolerability.

To satisfy customers’need, FCAD added prostaglandin analogues to its product line and gained great market shares in EU by cooperating with local partners.

“We take pride in fulfilling our promise of offering the best high quality chemicals to our customers. We have now added three prostaglandin analogues to our portfolio. These products are widely used for treating glaucoma. New research suggests that they can even be used for promoting eyelash growth. At FCAD, we make sure that all these products are manufactured exactly according to our customers’ needs. We are committed to become an innovative and sustainable company with a worldwide presence by fulfilling extensive and unique chemical needs,” a company official stated.

Key Products

1. Bimatoprost CAS 155206-00-1

2. Cloprostenol isopropyl ester CAS 157283-66-4

3. Travoprost CAS 157283-68-6

More Products For Sales

1. Bimatoprost CAS 155206-00-1

2. (+)-Cloprostenol Sodium CAS 62561-03-9

3. Cloprostenol isopropyl ester CAS 157283-66-4

4. 15S-Cloprostenol CAS 54276-22-1

5. Alprostadil CAS 745-65-3

6. Lubiprostone CAS 333963-40-9

7. Travoprost CAS 157283-68-6

8. Latanoprost CAS 130209-82-4